Evidence map›Paper›PMID 24958876›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Shigella reroutes host cell central metabolism to obtain high-flux nutrient supply for vigorous intracellular growth.

David Kentner, Giuseppe Martano, Morgane Callon, Petra Chiquet, Maj Brodmann, Olga Burton, Asa Wahlander, Paolo Nanni, Nathanaël Delmotte, Jonas Grossmann and 6 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. (p)ppGpp is required for virulence ofInfection and immunity · 2024
    Article
  5. Article
  6. Engineering Endosymbiotic Growth ofACS synthetic biology · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Microorganisms · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

David KentnerBiozentrum, University of Basel, 4056 Basel, Switzerland; david.kentner@gmx.de dirk.bumann@unibas.ch.
Giuseppe MartanoInstitute of Microbiology, Eidgenössiche Technische Hochschule Zürich, 8093 Zürich, Switzerland; and.
Morgane CallonBiozentrum, University of Basel, 4056 Basel, Switzerland;
Petra ChiquetBiozentrum, University of Basel, 4056 Basel, Switzerland;
Maj BrodmannBiozentrum, University of Basel, 4056 Basel, Switzerland;
Olga BurtonBiozentrum, University of Basel, 4056 Basel, Switzerland;
Asa WahlanderFunctional Genomics Center Zurich, 8057 Zürich, Switzerland.
Paolo NanniFunctional Genomics Center Zurich, 8057 Zürich, Switzerland.
Nathanaël DelmotteInstitute of Microbiology, Eidgenössiche Technische Hochschule Zürich, 8093 Zürich, Switzerland; and.
Jonas GrossmannFunctional Genomics Center Zurich, 8057 Zürich, Switzerland.
Julien LimenitakisBiozentrum, University of Basel, 4056 Basel, Switzerland;
Ralph SchlapbachFunctional Genomics Center Zurich, 8057 Zürich, Switzerland.
Patrick KieferInstitute of Microbiology, Eidgenössiche Technische Hochschule Zürich, 8093 Zürich, Switzerland; and.
Julia A VorholtInstitute of Microbiology, Eidgenössiche Technische Hochschule Zürich, 8093 Zürich, Switzerland; and.
Sebastian HillerBiozentrum, University of Basel, 4056 Basel, Switzerland;ORCID http://orcid.org/0000-0002-6709-4684
Dirk BumannBiozentrum, University of Basel, 4056 Basel, Switzerland; david.kentner@gmx.de dirk.bumann@unibas.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shigella flexneri proliferate in infected human epithelial cells at exceptionally high rates. This vigorous growth has important consequences for rapid progression to life-threatening bloody diarrhea, but the underlying metabolic mechanisms remain poorly understood. Here, we used metabolomics, proteomics, and genetic experiments to determine host and Shigella metabolism during infection in a cell culture model. The data suggest that infected host cells maintain largely normal fluxes through glycolytic pathways, but the entire output of these pathways is captured by Shigella, most likely in the form of pyruvate. This striking strategy provides Shigella with an abundant favorable energy source, while preserving host cell ATP generation, energy charge maintenance, and survival, despite ongoing vigorous exploitation. Shigella uses a simple three-step pathway to metabolize pyruvate at high rates with acetate as an excreted waste product. The crucial role of this pathway for Shigella intracellular growth suggests targets for antimicrobial chemotherapy of this devastating disease.

Indexed as

Cell DivisionAcetatesCarbonCytosolGenome, BacterialHeLa CellsHumansMetabolomicsNuclear Magnetic Resonance, BiomolecularOxygenPyruvic AcidShigellaAcetatesCarbonOxygenPyruvic Acidhost–pathogen interactionsinfectious diseases

Identifiers

PMID24958876
PMCPMC4103312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.